Brandi Flanagan
Family · Baton Rouge, LANPI 1871996157
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Organogenesis Inc. accounts for 83.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $834 and has fallen 63.1% since, to $307 in 2025.
Across 137 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$2K
- AbbVie$188
- Smith+Nephew$59
- KCI USA, Inc.$40
- Paratek Pharmaceuticals, Inc.$39
- Convatec Inc.$32
- plus $16 from 1 others
What the payments were for
- Food & beverage$2,295100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 115 | $1,920 |
| AbbVie | 11 | $188 |
| Smith+Nephew | 4 | $59 |
| KCI USA, Inc. | 2 | $40 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| Convatec Inc. | 2 | $32 |
| Tactile Systems Technology Inc | 1 | $16 |
How this compares
$2,295 in reported general payments places this provider in the 75th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 16 | $151 |
Paid to pharmacies, not to this prescriber.
Other family in Baton Rouge
- Elidia DewittBaton Rouge$108K
- Ghenet GhebretatiosBaton Rouge$91K
- Heather SullivanBaton Rouge$32K
- Randee KidderBaton Rouge$30K
- Dionne BellBaton Rouge$24K
- Jennifer LittleBaton Rouge$21K
- Tracy ParkerBaton Rouge$19K
- Kristen VillarBaton Rouge$18K
- Sharon JacksonBaton Rouge$15K
- Gloria MarchandBaton Rouge$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.